The Pediatric Obsessive Compulsive Disorder Treatment Study for Young Children (POTS jr): Developmental Considerations in the Rationale, Design, and Methods.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 23181244)

Published in J Obsessive Compuls Relat Disord on October 01, 2012

Authors

Jennifer Freeman1, Abbe Garcia, Kristen Benito, Christine Conelea, Jeffrey Sapyta, Muniya Khanna, John March, Martin Franklin

Author Affiliations

1: Alpert Medical School of Brown University, Bradley/Hasbro Children's Research Center, CORO West Building, Suite 204, 1 Hoppin St., Providence, RI, 02903, USA.

Articles cited by this

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry (1997) 41.93

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA (2004) 15.34

A children's global assessment scale (CGAS). Arch Gen Psychiatry (1983) 12.78

The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther (1995) 11.36

Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med (2008) 10.48

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry (1997) 7.10

The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry (1989) 6.98

The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Arch Gen Psychiatry (1985) 6.91

The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assess (2002) 4.29

Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behav Res Ther (1997) 4.00

Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry (1998) 3.80

Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA (2004) 3.51

Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet (1999) 3.11

The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics (2004) 2.82

Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. JAMA (2011) 2.49

Functional impairment in children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol (2003) 2.13

A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder. J Nerv Ment Dis (1993) 1.68

The epidemiology of obsessive-compulsive disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am (1999) 1.62

Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry (2004) 1.57

The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics (2004) 1.56

Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry (1988) 1.55

Family accommodation of obsessive-compulsive symptoms: instrument development and assessment of family behavior. J Nerv Ment Dis (1999) 1.52

Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach. J Am Acad Child Adolesc Psychiatry (2008) 1.46

Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol (1998) 1.41

Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry (2011) 1.29

A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry (1999) 1.29

The Children's Global Assessment Scale in clinical practice: an empirical evaluation. J Am Acad Child Adolesc Psychiatry (1994) 1.24

Cognitive behavioral treatment for young children with obsessive-compulsive disorder. Biol Psychiatry (2007) 1.15

Rationale and principles for early intervention with young children at risk for anxiety disorders. Clin Child Fam Psychol Rev (2002) 1.12

Functional impairment in clinical samples of Norwegian and Swedish children and adolescents with obsessive-compulsive disorder. Eur Child Adolesc Psychiatry (2005) 1.10

Is cognitive behavior therapy developmentally appropriate for young children? A critical review of the evidence. Clin Psychol Rev (2004) 1.09

Toward an integration of parent and clinician report on the Young Mania Rating Scale. J Affect Disord (2003) 1.06

Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q): reliability and validity. J Am Acad Child Adolesc Psychiatry (2006) 1.02

Phenomenology of Early Childhood Onset Obsessive Compulsive Disorder. J Psychopathol Behav Assess (2009) 0.99

Children with very early onset obsessive-compulsive disorder: clinical features and treatment outcome. J Child Psychol Psychiatry (2011) 0.83

Postinfectious and other forms of obsessive-compulsive disorder. Child Adolesc Psychiatr Clin N Am (1999) 0.78

Articles by these authors

Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry (2006) 2.95

Clinical characteristics of anxiety disordered youth. J Anxiety Disord (2010) 2.59

Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. JAMA (2011) 2.49

Treatment for Adolescents with Depression Study (TADS): safety results. J Am Acad Child Adolesc Psychiatry (2006) 2.45

A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. Am J Psychiatry (2008) 2.34

Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS. J Consult Clin Psychol (2011) 2.28

Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry (2006) 2.26

Recovery and recurrence following treatment for adolescent major depression. Arch Gen Psychiatry (2010) 1.89

Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry (2009) 1.51

Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry (2006) 1.38

Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry (2004) 1.34

The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry (2009) 1.24

Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry (2007) 1.21

Acute time to response in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry (2006) 1.16

Internet-delivered, family-based treatment for early-onset OCD: a preliminary case series. J Clin Child Adolesc Psychol (2013) 1.15

Onset of alcohol or substance use disorders following treatment for adolescent depression. J Consult Clin Psychol (2012) 1.10

Is trichotillomania a stereotypic movement disorder? An analysis of body-focused repetitive behaviors in people with hair-pulling. Ann Clin Psychiatry (2008) 1.06

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. J Am Acad Child Adolesc Psychiatry (2005) 1.05

Development and validation of a child version of the obsessive compulsive inventory. Behav Ther (2009) 1.03

Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale. J Am Acad Child Adolesc Psychiatry (2012) 1.00

Children's Florida Obsessive Compulsive Inventory: psychometric properties and feasibility of a self-report measure of obsessive-compulsive symptoms in youth. Child Psychiatry Hum Dev (2009) 0.99

Examining the Psychometric Properties of the Family Accommodation Scale-Parent-Report (FAS-PR). J Psychopathol Behav Assess (2009) 0.98

Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol (2006) 0.96

Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder. J Clin Psychiatry (2013) 0.93

Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study. J Child Adolesc Psychopharmacol (2002) 0.90

Evidence base update for psychosocial treatments for pediatric obsessive-compulsive disorder. J Clin Child Adolesc Psychol (2013) 0.90

Predictors of parental accommodation in pediatric obsessive-compulsive disorder: findings from the Pediatric Obsessive-Compulsive Disorder Treatment Study (POTS) trial. J Am Acad Child Adolesc Psychiatry (2011) 0.88

The child anxiety impact scale: examining parent- and child-reported impairment in child anxiety disorders. J Clin Child Adolesc Psychol (2013) 0.87

Depression, anxiety, and functional impairment in children with trichotillomania. Depress Anxiety (2009) 0.85

Ethnic differences among adolescents beginning treatment for depression. Cultur Divers Ethnic Minor Psychol (2010) 0.84

Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government. J Am Acad Child Adolesc Psychiatry (2006) 0.84

The Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity for use among 5 to 8 year olds with obsessive-compulsive disorder. J Abnorm Child Psychol (2011) 0.83

Depressed adolescents and comorbid psychiatric disorders: are there differences in the presentation of depression? J Abnorm Child Psychol (2008) 0.83

The ethical use of placebo in clinical trials involving children. J Child Adolesc Psychopharmacol (2004) 0.83

Testing tic suppression: comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit/hyperactivity disorder and Tourette's disorder. J Child Adolesc Psychopharmacol (2010) 0.83

The impact of neuropsychological functioning on treatment outcome in pediatric obsessive-compulsive disorder. Depress Anxiety (2010) 0.83

Patient adherence to cognitive-behavioral therapy predicts long-term outcome in obsessive-compulsive disorder. J Clin Psychiatry (2012) 0.82

Somatic complaints in anxious youth. Child Psychiatry Hum Dev (2014) 0.82

Symptom dimensions in obsessive-compulsive disorder: phenomenology and treatment outcomes with exposure and ritual prevention. Psychopathology (2013) 0.82

Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection? J Child Adolesc Psychopharmacol (2002) 0.81

Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry (2003) 0.81

Predicting antipsychotic use in children. Psychopharmacol Bull (2007) 0.80

Hepatitis C and depressive symptoms: psychological and social factors matter more than liver injury. Int J Psychiatry Med (2010) 0.80

Maternal and child expressed emotion as predictors of treatment response in pediatric obsessive-compulsive disorder. Child Psychiatry Hum Dev (2012) 0.79

CBT Specific Process in Exposure-Based Treatments: Initial Examination in a Pediatric OCD Sample. J Obsessive Compuls Relat Disord (2012) 0.78

A cluster randomized trial to evaluate external support for the implementation of positive behavioral interventions and supports by school personnel. Implement Sci (2014) 0.78

Parental anxiety as a predictor of medication and CBT response for anxious youth. Child Psychiatry Hum Dev (2015) 0.78

The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth. J Consult Clin Psychol (2013) 0.77

Symptom profiles in pediatric obsessive-compulsive disorder (OCD): the effects of comorbid grooming conditions. J Anxiety Disord (2009) 0.77

Affective and sensory correlates of hair pulling in pediatric trichotillomania. Behav Modif (2009) 0.77

Assessing anxiety in youth with the multidimensional anxiety scale for children. J Clin Child Adolesc Psychol (2013) 0.76

Predictors of patient adherence to cognitive-behavioral therapy for obsessive-compulsive disorder. Psychother Psychosom (2012) 0.75

Pharmacological management of treatment-resistant pediatric depression. J Am Acad Child Adolesc Psychiatry (2005) 0.75

"Not Just Right Experiences" in adolescents: phenomenology and associated characteristics. Child Psychiatry Hum Dev (2014) 0.75